Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Biolase
(NASDAQ:BIOL)
Intraday
$0.15
0.0031
[2.11%]
After-Hours
$0.15
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.15
0.0031
[2.11%]
At close: Apr 18
$0.15
0
[0.00%]
After Hours: 7:44PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Biolase Stock (NASDAQ:BIOL)
Biolase Stock (NASDAQ: BIOL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 11, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Apr 11, 2024, 4:31PM
Wednesday, April 10, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Apr 10, 2024, 4:31PM
Monday, April 01, 2024
Ascendiant Capital Maintains Buy on Biolase, Lowers Price Target to $4
Benzinga Newsdesk
-
Apr 1, 2024, 5:40AM
Friday, March 22, 2024
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Mar 22, 2024, 2:39PM
Benchmark Maintains Speculative Buy on Biolase, Lowers Price Target to $0.4
Benzinga Newsdesk
-
Mar 22, 2024, 1:42PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Mar 22, 2024, 1:31PM
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
Avi Kapoor
-
Mar 22, 2024, 12:18PM
Why BIOLASE Shares Are Surging Friday
Lekha Gupta
-
Mar 22, 2024, 11:13AM
US Stocks Edge Lower; FedEx Posts Upbeat Earnings
Avi Kapoor
-
Mar 22, 2024, 9:45AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Mar 22, 2024, 9:06AM
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 22, 2024, 8:10AM
Biolase shares are trading higher after the company reported better-than-expected Q4 EPS results.
Benzinga Newsdesk
-
Mar 22, 2024, 7:45AM
Thursday, March 21, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Mar 21, 2024, 5:33PM
Biolase Anticipates Q1 Net Revenue To Exceed $10M, Relatively Flat Y/Y (Est $10.796M); 2024 Net Revenue To Increase 6%-8% To $52M-$53M (Est $53.068M)
Benzinga Newsdesk
-
Mar 21, 2024, 4:55PM
Biolase shares are trading higher after the company reported better-than-expected Q4 EPS results.
Benzinga Newsdesk
-
Mar 21, 2024, 4:27PM
Recap: Biolase Q4 Earnings
Benzinga Insights
-
Mar 21, 2024, 4:20PM
Biolase Q4 EPS $(1.76) Beats $(2.55) Estimate, Sales $13.49M Miss $13.55M Estimate
Benzinga Newsdesk
-
Mar 21, 2024, 4:16PM
Earnings Scheduled For March 21, 2024
Benzinga Insights
-
Mar 21, 2024, 6:15AM
Wednesday, March 20, 2024
Earnings Preview For Biolase
Benzinga Insights
-
Mar 20, 2024, 1:00PM
Friday, March 01, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Mar 1, 2024, 4:32PM
Thursday, February 22, 2024
BIOLASE, Inc. Launched Its State-of-the-art All-tissue Laser System, Waterlase iPlus Premier Edition, And Will Be Debuting It At The Chicago Midwinter Meeting 2024
Benzinga Newsdesk
-
Feb 22, 2024, 6:44AM
Tuesday, February 13, 2024
Nasdaq Down Over 2%; Marriott Earnings Top Views
Avi Kapoor
-
Feb 13, 2024, 2:26PM
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Feb 13, 2024, 1:13PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Feb 13, 2024, 12:31PM
Gold Down Over 1%; Coca-Cola Posts Upbeat Sales
Avi Kapoor
-
Feb 13, 2024, 12:06PM
Biolase shares are trading lower after the company announced pricing of a $7 million public offering.
Benzinga Newsdesk
-
Feb 13, 2024, 11:56AM
Dow Dips Over 300 Points; US Annual Inflation Slows to 3.1% In January
Avi Kapoor
-
Feb 13, 2024, 9:43AM
BIOLASE, Inc. Announces Pricing Of $7M Public Offering Of 16M Units At A Price Of $0.44/Unit
Benzinga Newsdesk
-
Feb 13, 2024, 9:18AM
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Feb 9, 2024, 4:31PM
Top 5 Health Care Stocks That Are Preparing To Pump In February
Avi Kapoor
-
Feb 9, 2024, 8:35AM
Wednesday, February 07, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Feb 7, 2024, 12:31PM
Tuesday, February 06, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Feb 6, 2024, 12:31PM
Wednesday, January 31, 2024
Biolase Filed For Offering On A Best Efforts Basis Up To 8.8M Units
Charles Gross
-
Jan 31, 2024, 6:08AM
Monday, January 29, 2024
Biolase Expects Full-Year 2024 Revenue Of $52M-$53M, Up 6%-8% Y/Y Compared To The Consensus Of $53.01M; The Company Expects To Improves Loss From Operations By 50%-60%
Benzinga Newsdesk
-
Jan 29, 2024, 6:37AM
Biolase Reports Full-year 2023 Interim Revenue Of $48.9M-$49.2M, Up 1% Y/Y Compared To The Consensus Of $49.21M
Benzinga Newsdesk
-
Jan 29, 2024, 6:35AM
Tuesday, January 02, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Jan 2, 2024, 4:31PM
Tuesday, December 12, 2023
Biolase Announced Completion Of A Trial Program Featuring The Waterlase iPlus All Tissue Laser
Benzinga Newsdesk
-
Dec 12, 2023, 4:12PM
Wednesday, December 06, 2023
BIOLASE, Inc. Announces Pricing Of $1.4M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Benzinga Newsdesk
-
Dec 6, 2023, 1:47PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Dec 6, 2023, 8:06AM
Monday, December 04, 2023
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Dec 4, 2023, 1:10PM
Friday, November 10, 2023
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Nov 10, 2023, 1:34PM
Biolase shares are trading lower after the company reported worse-than-expected Q3 financial results.
Benzinga Newsdesk
-
Nov 10, 2023, 11:42AM
Why Direct Digital Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Nov 10, 2023, 8:08AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Nov 10, 2023, 8:07AM
Thursday, November 09, 2023
Biolase Q3 2023 Gaap EPS $(3.89) Misses $(1.85) Estimate, Sales $10.92M Miss $13.96M Estimate
Benzinga Newsdesk
-
Nov 9, 2023, 5:00PM
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Nov 9, 2023, 4:31PM
Earnings Scheduled For November 9, 2023
Benzinga Insights
-
Nov 9, 2023, 6:52AM
Wednesday, November 08, 2023
A Preview Of Biolase's Earnings
Benzinga Insights
-
Nov 8, 2023, 2:02PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Nov 8, 2023, 8:06AM
BIOLASE Reports Findings From 12-Month Follow-up To Clinical Trial Performed At The McGuire Institute
Benzinga Newsdesk
-
Nov 8, 2023, 6:35AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch